MaxLinear (MXL) has had the highest return between April 6, 2026 and July 6, 2026 by a mid-cap US stock, returning 419.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
MaxLinear (MXL) | 4/6/2026 - 7/6/2026 | 419.93% |
P3 Health Partners (PIII) | 4/6/2026 - 7/6/2026 | 342.41% |
Sellas Life Sciences (SLS) | 4/6/2026 - 7/6/2026 | 253.3% |
BlackBerry (BB) | 4/6/2026 - 7/6/2026 | 230.75% |
Clover Health Investments (CLOV) | 4/6/2026 - 7/6/2026 | 204.05% |
Penguin Solutions (PENG) | 4/6/2026 - 7/6/2026 | 198.98% |
Sezzle (SEZL) | 4/6/2026 - 7/6/2026 | 180.66% |
Oscar Health (OSCR) | 4/6/2026 - 7/6/2026 | 168.17% |
Anterix (ATEX) | 4/6/2026 - 7/6/2026 | 163.18% |
Maase (MAAS) | 4/6/2026 - 7/6/2026 | 156.92% |
Ouster, Inc Common Stock (OUST) | 4/6/2026 - 7/6/2026 | 152.48% |
Vishay Intertechnology (VSH) | 4/6/2026 - 7/6/2026 | 147.42% |
Uniqure (QURE) | 4/6/2026 - 7/6/2026 | 142.38% |
Acm Research (ACMR) | 4/6/2026 - 7/6/2026 | 137.77% |
Abcellera Biologics (ABCL) | 4/6/2026 - 7/6/2026 | 128.45% |
Dave (DAVE) | 4/6/2026 - 7/6/2026 | 122.62% |
Bitfarms (KEEL) | 4/6/2026 - 7/6/2026 | 121.74% |
Tenable (TENB) | 4/6/2026 - 7/6/2026 | 117.59% |
Xometry (XMTR) | 4/6/2026 - 7/6/2026 | 117.16% |
Hinge Health (HNGE) | 4/6/2026 - 7/6/2026 | 115.51% |
Definium Therapeutics (DFTX) | 4/6/2026 - 7/6/2026 | 115.35% |
Corcept Therapeutics (CORT) | 4/6/2026 - 7/6/2026 | 113.97% |
Pattern Group Inc Series A Common Stock (PTRN) | 4/6/2026 - 7/6/2026 | 113.83% |
Organon (OGN) | 4/6/2026 - 7/6/2026 | 113.71% |
Navan, Inc Class A Common Stock (NAVN) | 4/6/2026 - 7/6/2026 | 112.85% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.